Serum prolactin in coeliac disease: A marker for disease activity

Ram Reifen*, Dan Buskila, Moshe Maislos, Joseph Press, Aaron Lerner

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


Prolactin, a polypeptide hormone of anterior pituitary origin, has pronounced physiological effects on growth, reproduction, and osmoregulation. Increasing evidence indicates that prolactin also has an immunomodulatory influence on the immune system. The status of prolactin in patients with coellac disease was investigated by obtaining serum samples from 48 patients with active and non-active coeliac disease. These were compared with samples from 20 children with familial Mediterranean fever and 65 normal controls. Serum prolactin in patients with active coeliac disease was significantly higher than in the other groups studied and reference values. Serum prolactin correlated well with the degree of mucosal atrophy and with the serum concentration of antiendomysial antibodies. Prolactin may play a part in immune modulation in the intestinal damage of coeliac disease and serve as a potential marker for disease activity.

Original languageAmerican English
Pages (from-to)155-157
Number of pages3
JournalArchives of Disease in Childhood
Issue number2
StatePublished - 1997


  • Coeliac disease
  • Prolactin


Dive into the research topics of 'Serum prolactin in coeliac disease: A marker for disease activity'. Together they form a unique fingerprint.

Cite this